Literature DB >> 20858849

Gray- and white-matter changes 1 year after first clinical episode of multiple sclerosis: MR imaging.

Eytan Raz1, Mara Cercignani, Emilia Sbardella, Porzia Totaro, Carlo Pozzilli, Marco Bozzali, Patrizia Pantano.   

Abstract

PURPOSE: To assess, by means of magnetic resonance (MR) imaging, the longitudinal changes in white matter (WM) and gray matter (GM) in a cohort of patients with clinically isolated syndrome (CIS) who were followed up for 1 year.
MATERIALS AND METHODS: This prospective, HIPAA-compliant study was approved by the institutional review board. Written informed consent was obtained from all the participants. Changes in GM and WM integrity were respectively investigated by using three-dimensional T1-weighted and diffusion-tensor (DT) imaging sequences and by applying voxel-based morphometry (VBM) and tract-based spatial statistics (TBSS) analyses. Thirty-four consecutive patients (21 women, 13 men; mean age, 32.8 years ± 7.7 [standard deviation]) who had CIS were recruited. All the patients underwent a neurologic and an MR examination at baseline and 12 months later; the MR examination consisted of three-dimensional T1-weighted dual-echo turbo spin-echo DT imaging. VBM and TBSS were used to analyze GM volume and WM fractional anisotropy, respectively.
RESULTS: After 1 year, multiple sclerosis (MS) was diagnosed in 33 (97%) of 34 patients with CIS. Longitudinal volumetric analysis revealed a significant (P < .001) reduction in global GM volume. The VBM analysis showed the development of regional GM atrophy involving several cortical and subcortical regions in both hemispheres (P < .05). No significant longitudinal change in global or regional WM fractional anisotropy was otherwise observed.
CONCLUSION: WM damage was detectable early and involved most fiber tracts in patients with MS, but it did not worsen significantly during the 1st year after clinical onset. In contrast, GM damage was not detectable at the time of clinical onset, but a significant decrease in cortical and deep GM volume was observed at 1 year. © RSNA, 2010.

Entities:  

Mesh:

Year:  2010        PMID: 20858849     DOI: 10.1148/radiol.10100626

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  33 in total

1.  MRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometry.

Authors:  Kerstin Bendfeldt; Bernd Taschler; Laura Gaetano; Philip Madoerin; Pascal Kuster; Nicole Mueller-Lenke; Michael Amann; Hugo Vrenken; Viktor Wottschel; Frederik Barkhof; Stefan Borgwardt; Stefan Klöppel; Eva-Maria Wicklein; Ludwig Kappos; Gilles Edan; Mark S Freedman; Xavier Montalbán; Hans-Peter Hartung; Christoph Pohl; Rupert Sandbrink; Till Sprenger; Ernst-Wilhelm Radue; Jens Wuerfel; Thomas E Nichols
Journal:  Brain Imaging Behav       Date:  2019-10       Impact factor: 3.978

Review 2.  The Relevance of Neuroimaging Findings to Physical Disability in Multiple Sclerosis.

Authors:  Rahşan Göçmen
Journal:  Noro Psikiyatr Ars       Date:  2018       Impact factor: 1.339

3.  Iron deposition on SWI-filtered phase in the subcortical deep gray matter of patients with clinically isolated syndrome may precede structure-specific atrophy.

Authors:  J Hagemeier; B Weinstock-Guttman; N Bergsland; M Heininen-Brown; E Carl; C Kennedy; C Magnano; D Hojnacki; M G Dwyer; R Zivadinov
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-29       Impact factor: 3.825

4.  Longitudinal Mixed-Effect Model Analysis of the Association between Global and Tissue-Specific Brain Atrophy and Lesion Accumulation in Patients with Clinically Isolated Syndrome.

Authors:  M Varosanec; T Uher; D Horakova; J Hagemeier; N Bergsland; M Tyblova; Z Seidl; M Vaneckova; J Krasensky; M G Dwyer; E Havrdova; R Zivadinov
Journal:  AJNR Am J Neuroradiol       Date:  2015-06-25       Impact factor: 3.825

5.  Subcortical and cortical gray matter atrophy in a large sample of patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis.

Authors:  N Bergsland; D Horakova; M G Dwyer; O Dolezal; Z K Seidl; M Vaneckova; J Krasensky; E Havrdova; R Zivadinov
Journal:  AJNR Am J Neuroradiol       Date:  2012-04-12       Impact factor: 3.825

6.  Cerebral gray matter volumes and low-frequency fluctuation of BOLD signals in cocaine dependence: duration of use and gender difference.

Authors:  Jaime S Ide; Sheng Zhang; Sien Hu; Rajita Sinha; Carolyn M Mazure; Chiang-Shan R Li
Journal:  Drug Alcohol Depend       Date:  2013-09-17       Impact factor: 4.492

7.  A novel approach with "skeletonised MTR" measures tract-specific microstructural changes in early primary-progressive MS.

Authors:  Benedetta Bodini; Mara Cercignani; Ahmed Toosy; Nicola De Stefano; David H Miller; Alan J Thompson; Olga Ciccarelli
Journal:  Hum Brain Mapp       Date:  2013-04-24       Impact factor: 5.038

8.  Disability-Specific Atlases of Gray Matter Loss in Relapsing-Remitting Multiple Sclerosis.

Authors:  Allan MacKenzie-Graham; Florian Kurth; Yuichiro Itoh; He-Jing Wang; Michael J Montag; Robert Elashoff; Rhonda R Voskuhl
Journal:  JAMA Neurol       Date:  2016-08-01       Impact factor: 18.302

Review 9.  Imaging multiple sclerosis and other neurodegenerative diseases.

Authors:  Matilde Inglese; Maria Petracca
Journal:  Prion       Date:  2012-11-01       Impact factor: 3.931

Review 10.  The prognostic utility of MRI in clinically isolated syndrome: a literature review.

Authors:  C Odenthal; A Coulthard
Journal:  AJNR Am J Neuroradiol       Date:  2014-05-15       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.